+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Services Market - Global Forecast 2026-2032- Product Image
Drug Discovery Services Market - Global Forecast 2026-2032- Product Image
New

Drug Discovery Services Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5146254
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug discovery services market is experiencing accelerated transformation as innovation, digital advances, and business model evolution converge. Senior leaders navigating this environment must balance scientific rigor with operational agility to realize strategic advantage across the value chain.

Market Snapshot: Drug Discovery Services Market Growth

The Drug Discovery Services Market grew from USD 28.49 billion in 2025 to USD 32.73 billion in 2026. Forecasts indicate continued expansion at a CAGR of 15.06%, reaching USD 76.09 billion by 2032.

Scope & Segmentation Analysis

This report offers a comprehensive analysis of the global drug discovery services sector across essential service types, technologies, molecules, end-users, and regions:

  • Service Types: ADME DMPK testing, biomarker discovery, compound synthesis and scale-up, hit screening, lead optimization, target identification, toxicity testing.
  • ADME DMPK Subcategories: Bioanalytical services, in vitro ADME, in vivo pharmacokinetics.
  • Biomarker Discovery Subcategories: Genomic, metabolomic, and proteomic biomarkers.
  • Compound Synthesis: Custom synthesis, GMP manufacturing, process development.
  • Hit Screening: Fragment, high-content, high-throughput, and virtual screening.
  • Lead Optimization: ADMET prediction, computational chemistry, medicinal chemistry, structure-based design.
  • Target Identification: Bioinformatics, genomics, high-content screening, proteomics.
  • Toxicity Testing: In vitro toxicology, in vivo toxicology, safety pharmacology.
  • Technologies: Computational biology, flow cytometry, mass spectrometry, nuclear magnetic resonance, X-ray crystallography, high-throughput screening.
  • Computational Biology Components: Bioinformatics, cheminformatics, molecular modeling.
  • High-Throughput Screening Types: Biochemical, cell-based, and label-free assays.
  • Molecule Types: Biologics, oligonucleotides, peptides, small molecules.
  • End Users: Academic institutions, biotechnology companies, contract research organizations, pharmaceutical companies.
  • Therapeutic Areas: Cardiovascular, CNS disorders, infectious diseases, metabolic disorders, oncology.
  • Regions: Americas, Europe Middle East & Africa, Asia-Pacific.

Key Takeaways: Strategic Insights for Decision-Makers

  • Market momentum is driven by converging technological innovation and operational shifts, enabling faster and more precise discovery workflows for new medicines.
  • Providers are integrating computational biology with high-throughput laboratory capabilities, reinforcing the seamless transition from early-stage modeling to empirical validation.
  • Flexible commercial and delivery models are aligning with the needs of pharma and biotech organizations, allowing outsourcing of critical phases while ensuring operational focus.
  • Investment in interoperable data architectures and multidisciplinary talent is paramount to facilitate cross-border and cross-functional collaboration.
  • Differentiation increasingly centers on service integration, robust data standards, and experience with complex molecule types and therapeutic areas.
  • Strategic partnerships and targeted M&A enable organizations to close gaps in technical expertise and regional capabilities efficiently.

Tariff Impact: Supply Chain and Regional Strategy

U.S. tariffs introduced in 2025 created new challenges in sourcing instruments and components for laboratories, increasing both costs and administrative requirements. In response, organizations accelerated supplier diversification, localized sourcing, and regional warehousing. Collaborative efforts between regulatory, scientific, and procurement teams ensured that alternates and regional substitutions met rigorous validation and compliance standards. As a lasting effect, regional capability building and operational resilience are now central themes in strategic decision-making for global supply chains.

Methodology & Data Sources

Research for this report applies a mixed-methods approach, combining structured interviews with senior stakeholders, thorough review of scientific and regulatory literature, and independent cross-validation through industry announcements and filings. Triangulation ensures accuracy, minimizes bias, and grounds observations in reproducible data and current practices.

Why This Report Matters

  • Clarifies operational and strategic options for optimizing drug discovery partnerships, supply chains, and investments.
  • Enables senior decision-makers to identify high-growth opportunity corridors by illuminating intersections of technology, service, and regional capability.
  • Supports risk mitigation and resilience planning as organizations adapt to evolving regulatory, supply chain, and scientific dynamics.

Conclusion

The drug discovery services sector is progressing toward deeper integration, data-driven collaboration, and resilient operations. By aligning strategy with detailed market insights, organizations can secure competitive positioning in an evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Drug Discovery Services Market, by Service Type
8.1. Adme Dmpk Testing
8.1.1. Bioanalytical Services
8.1.2. In Vitro Adme
8.1.3. In Vivo Pharmacokinetics
8.2. Biomarker Discovery
8.2.1. Genomic Biomarkers
8.2.2. Metabolomic Biomarkers
8.2.3. Proteomic Biomarkers
8.3. Compound Synthesis & Scale Up
8.3.1. Custom Synthesis
8.3.2. Gmp Manufacturing
8.3.3. Process Development
8.4. Hit Screening
8.4.1. Fragment Screening
8.4.2. High Content Screening
8.4.3. High Throughput Screening
8.4.4. Virtual Screening
8.5. Lead Optimization
8.5.1. Admet Prediction
8.5.2. Computational Chemistry
8.5.3. Medicinal Chemistry
8.5.4. Structure Based Design
8.6. Target Identification
8.6.1. Bioinformatics
8.6.2. Genomics
8.6.3. High Content Screening
8.6.4. Proteomics
8.7. Toxicity Testing
8.7.1. In Vitro Toxicology
8.7.2. In Vivo Toxicology
8.7.3. Safety Pharmacology
9. Drug Discovery Services Market, by Technology
9.1. Computational Biology
9.1.1. Bioinformatics
9.1.2. Cheminformatics
9.1.3. Molecular Modeling
9.2. Flow Cytometry
9.3. High Throughput Screening
9.3.1. Biochemical Assays
9.3.2. Cell Based Assays
9.3.3. Label Free Assays
9.4. Mass Spectrometry
9.5. Nuclear Magnetic Resonance
9.6. X Ray Crystallography
10. Drug Discovery Services Market, by Molecule Type
10.1. Biologics
10.2. Oligonucleotides
10.3. Peptides
10.4. Small Molecules
11. Drug Discovery Services Market, by End User
11.1. Academic Institutions
11.2. Biotechnology Companies
11.3. Contract Research Organizations
11.4. Pharmaceutical Companies
12. Drug Discovery Services Market, by Therapeutic Area
12.1. Cardiovascular Disorders
12.2. Central Nervous System Disorders
12.3. Infectious Diseases
12.4. Metabolic Disorders
12.5. Oncology
13. Drug Discovery Services Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Drug Discovery Services Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Drug Discovery Services Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Drug Discovery Services Market
17. China Drug Discovery Services Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Charles River Laboratories International, Inc.
18.6. Drug Hunter Inc.
18.7. Eurofins Scientific SE
18.8. Evotec SE
18.9. IQVIA Holdings Inc.
18.10. Labcorp.
18.11. Sai Life Sciences Limited
18.12. Syngene International Ltd.
18.13. TheraIndx Lifesciences Pvt. Ltd.
18.14. Thermo Fisher Scientific Inc.
18.15. Vipragen Biosciences Private Limited
List of Figures
FIGURE 1. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO ADME, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO ADME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO ADME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO PHARMACOKINETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO PHARMACOKINETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO PHARMACOKINETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMIC BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMIC BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMIC BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMIC BIOMARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMIC BIOMARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMIC BIOMARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CUSTOM SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CUSTOM SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GMP MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GMP MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GMP MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FRAGMENT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FRAGMENT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FRAGMENT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY VIRTUAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY VIRTUAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADMET PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADMET PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO TOXICOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO TOXICOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO TOXICOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO TOXICOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO TOXICOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO TOXICOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SAFETY PHARMACOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SAFETY PHARMACOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMINFORMATICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMINFORMATICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMINFORMATICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CELL BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CELL BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LABEL FREE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LABEL FREE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LABEL FREE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 187. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 188. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 194. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 196. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 245. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 247. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 248. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 249. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 250. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 251. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 252. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 253. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 254. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 255. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 256. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 257. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 258. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 259. EUROPE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 275. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 277. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 278. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 279. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 280. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 281. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 282. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 283. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 284. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 285. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2032 (USD MILLION)
TABLE 286. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 287. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 288. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARK

Companies Mentioned

The key companies profiled in this Drug Discovery Services market report include:
  • Charles River Laboratories International, Inc.
  • Drug Hunter Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • IQVIA Holdings Inc.
  • Labcorp.
  • Sai Life Sciences Limited
  • Syngene International Ltd.
  • TheraIndx Lifesciences Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Vipragen Biosciences Private Limited

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 32.73 Billion
Forecasted Market Value ( USD ) by 2032 $ 76.09 Billion
Compound Annual Growth Rate15.0%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Drug Discovery Services - Global Strategic Business Report - Product Image

Drug Discovery Services - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Drug Discovery Services - Company Evaluation Report, 2025 - Product Image

Drug Discovery Services - Company Evaluation Report, 2025

  • Report
  • 155 Pages
  • Global
From
Drug Discovery Services Market - Product Image

Drug Discovery Services Market

  • Report
  • 150 Pages
  • Global
From
Drug Discovery Services Market Report 2025 - Product Image

Drug Discovery Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030 - Product Image

Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030

  • Report
  • 451 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.